Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Annemieke J. Lem"'
Autor:
Judith S Renes, Maria A J de Ridder, Petra E Breukhoven, Annemieke J Lem, Anita C S Hokken-Koelega
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e53164 (2012)
BACKGROUND: Growth hormone (GH) treatment has become a frequently applied growth promoting therapy in short children born small for gestational age (SGA). Children born SGA have a higher risk of developing attention deficit hyperactivity disorder (AD
Externí odkaz:
https://doaj.org/article/2e800b64592b4e62a2c8d17e05d67275
Autor:
Manouk van der Steen, Annemieke J. Lem, Anita C. S. Hokken-Koelega, Danielle C. M. van der Kaay
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 101(2), 705-713. Endocrine Society
Pubertal children born small for gestational age with a poor adult height (AH) expectation can benefit from treatment with GH 1 mg/m(2)/d (∼0.033 mg/kg/d) in combination with 2 years of GnRH analog (GnRHa) and even more so with GH 2 mg/m(2)/d. Beca
Autor:
Manouk van der Steen, Anita C. S. Hokken-Koèelega, Danielle C. M. van der Kaay, Annemieke J. Lem
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 101(5), 2005-2012. Endocrine Society
Context: Most studies on puberty in children born small for gestational age (SGA) report height and age at onset of puberty. GH-treated SGA children with an adult height (AH) expectation below −2.5 SDS at onset of puberty can benefit from an additi
Autor:
Anita C. S. Hokken-Koelega, R. J. Odink, Manouk van der Steen, Floor S. Neijens, Willie M. Bakker-van Waarde, Ciska Westerlaken, Danielle C. M. van der Kaay, Cees Noordam, Annemieke J. Lem, Flip J. P. C. M. van der Hulst, Wilma Oostdijk, E J Schroor
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 100, 10, pp. 3725-34
Journal of Clinical Endocrinology and Metabolism, 100(10), 3725-3734. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(10), 3725-3734
Journal of Clinical Endocrinology and Metabolism, 100, 3725-34
Journal of Clinical Endocrinology and Metabolism, 100(10), 3725-3734. ENDOCRINE SOC
Journal of Clinical Endocrinology and Metabolism, 100(10), 3725-3734. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(10), 3725-3734
Journal of Clinical Endocrinology and Metabolism, 100, 3725-34
Journal of Clinical Endocrinology and Metabolism, 100(10), 3725-3734. ENDOCRINE SOC
Item does not contain fulltext CONTEXT: Previously we showed that pubertal children born small for gestational age (SGA) with a poor adult height (AH) expectation can benefit from treatment with GH 1 mg/m(2) per day ( approximately 0.033 mg/kg/d) in
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 98(1), 77-86. Endocrine Society
Postponement of puberty by GnRH analog (GnRHa) in addition to GH treatment might increase adult height (AH) in short adolescents born small for gestational age (SGA). GnRHa treatment is thought to have negative effects on bone mineral density (BMD) a
Autor:
E J Schroor, Wilma Oostdijk, Roel J. Odink, Maria A. J. de Ridder, Danielle C. M. van der Kaay, Willie M. Bakker-van Waarde, Anita C. S. Hokken-Koelega, Ciska Westerlaken, Annemieke J. Lem, Cees Noordam, Eric J. Sulkers, Flip J. P. C. M. van der Hulst, Jaap Mulder
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 97(11), 4096-4105
Journal of Clinical Endocrinology and Metabolism, 97(11), 4096-4105. ENDOCRINE SOC
Journal of Clinical Endocrinology and Metabolism, 97(11), 4096-4105. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 97, 4096-105
Journal of Clinical Endocrinology and Metabolism, 97, 11, pp. 4096-105
Journal of Clinical Endocrinology and Metabolism, 97(11), 4096-4105. ENDOCRINE SOC
Journal of Clinical Endocrinology and Metabolism, 97(11), 4096-4105. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 97, 4096-105
Journal of Clinical Endocrinology and Metabolism, 97, 11, pp. 4096-105
Context: GH treatment is effective in improving height in short children born small for gestational age (SGA). GH is thought to have limited effect when started during adolescence.Objective: The aim of this study was to investigate GH treatment effic
Publikováno v:
Clinical Endocrinology. 73:355-360
Summary Context The criteria for starting growth hormone (GH), an approved treatment for short children born small for gestational age (SGA), differ between Europe and the USA. One European requirement for starting GH, a distance to target height (DT
Autor:
Judith S. Renes, J. van Doorn, Annemieke J. Lem, Petra E. Breukhoven, M A J de Ridder, A.C.S. Hokken-Koelega
Publikováno v:
Hormone Research in Paediatrics, 81(2), 126-132. Karger
Aims: To determine acid-labile subunit (ALS) levels in short small for gestational age (SGA) children and to assess the relationship between ALS levels and several clinical and laboratory characteristics. Also, to assess whether adding ALS levels to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7049dc3e94f9c464e38fb924fce2fd9
https://pure.eur.nl/en/publications/af200e05-bfa9-4ace-a154-a78cb28596bb
https://pure.eur.nl/en/publications/af200e05-bfa9-4ace-a154-a78cb28596bb
Autor:
Annemieke J. Lem, Judith S. Renes, Anita Hokken-Koelega, Petra E. Breukhoven, Maria A. J. de Ridder
Publikováno v:
PLoS ONE
PLoS One (print), 7(12). Public Library of Science
PLoS ONE, Vol 7, Iss 12, p e53164 (2012)
PLoS One (print), 7(12). Public Library of Science
PLoS ONE, Vol 7, Iss 12, p e53164 (2012)
textabstractBackground: Growth hormone (GH) treatment has become a frequently applied growth promoting therapy in short children born small for gestational age (SGA). Children born SGA have a higher risk of developing attention deficit hyperactivity
Autor:
Inge Jobse, Danielle C. M. van der Kaay, Anita C. S. Hokken-Koelega, Hein Raat, Maria A. J. de Ridder, Annemieke J. Lem
Publikováno v:
Hormone Research in Paediatrics, 77(3). Karger
Aims: To investigate health-related quality of life (HRQoL) in short children born small for gestational age (SGA) during growth hormone (GH) treatment and additional postponement of puberty by gonadotropin-releasing hormone analogue (GnRHa). Methods